Related Experiment Videos
The evolving knowledge on primary hemostasis in neonates
Lorenzo Zanetto1, Elena Campello2, Mariella Magarotto1
1Padua University Hospital, Neonatal Intensive Care Unit, Department of Women's and Children's Health, Veneto, Italy, Padua.
Seminars in Thrombosis and Hemostasis
|August 10, 2026
Summary
Neonatal bleeding risk is complex, involving more than just platelet function. Research suggests platelet hyporeactivity may be part of a balanced system, but its role in infant bleeding requires further study.
Area of Science:
- Neonatal physiology
- Hemostasis and thrombosis
- Pediatric hematology
Background:
- Traditionally, platelet dysfunction was considered the primary cause of neonatal bleeding.
- Emerging evidence suggests platelet hyporeactivity may be a regulated component of neonatal hemostasis.
Purpose of the Study:
- To review primary hemostasis in neonates, considering factors beyond platelet function.
- To integrate evidence from various study types on neonatal hemostasis.
Main Methods:
- Literature review integrating in-vitro, laboratory, and point-of-care studies.
- Analysis of factors influencing platelet function and interaction with other blood components.
- Exploration of molecular and technological advancements in studying neonatal hemostasis.
Main Results:
- Studies indicate potential platelet dysfunction contributes to bleeding risk, particularly in preterm infants.
- Clinical relevance is uncertain due to methodological variations and limited outcome correlation.
- Neonatal hemostasis involves unique plasma protein functions and higher hematocrit, enhancing adhesion.
Conclusions:
- Neonatal primary hemostasis is a unique, balanced system.
- Platelet hyporeactivity may result from developmental factors or inhibitory pathways.
- Further research is needed on neonatal therapies' impact on hemostatic balance.